Figure 1From: Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy Metastases in the liver of patient 10 showing the lesions on CT (left), 177 Lu-peptide SPECT/CT (middle) and FDG-PET/CT (right). The arrow indicates the lesion that was used for the tumor dosimetry.Back to article page